- Home
- IMCR vs SFL Comparison
IMCR vs SFL Comparison
Compare IMCR & SFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCR
- SFL
- Stock Information
- Founded
- IMCR 2008
- SFL 2003
- Country
- IMCR United Kingdom
- SFL Bermuda
- Employees
- IMCR N/A
- SFL N/A
- Industry
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- SFL Marine Transportation
- Sector
- IMCR Health Care
- SFL Consumer Discretionary
- Exchange
- IMCR Nasdaq
- SFL Nasdaq
- Market Cap
- IMCR 1.5B
- SFL 1.1B
- IPO Year
- IMCR 2021
- SFL N/A
- Fundamental
- Price
- IMCR $32.80
- SFL $8.85
- Analyst Decision
- IMCR Buy
- SFL Strong Buy
- Analyst Count
- IMCR 10
- SFL 1
- Target Price
- IMCR $58.13
- SFL $13.00
- AVG Volume (30 Days)
- IMCR 444.9K
- SFL 1.3M
- Earning Date
- IMCR 08-07-2025
- SFL 08-13-2025
- Dividend Yield
- IMCR N/A
- SFL 12.13%
- EPS Growth
- IMCR N/A
- SFL N/A
- EPS
- IMCR N/A
- SFL 0.41
- Revenue
- IMCR $333,581,000.00
- SFL $852,590,000.00
- Revenue This Year
- IMCR $26.82
- SFL N/A
- Revenue Next Year
- IMCR $8.15
- SFL $3.20
- P/E Ratio
- IMCR N/A
- SFL $21.93
- Revenue Growth
- IMCR 25.75
- SFL 6.58
- 52 Week Low
- IMCR $23.15
- SFL $6.78
- 52 Week High
- IMCR $41.54
- SFL $14.14
- Technical
- Relative Strength Index (RSI)
- IMCR 51.47
- SFL 59.48
- Support Level
- IMCR $30.76
- SFL $8.21
- Resistance Level
- IMCR $33.95
- SFL $8.69
- Average True Range (ATR)
- IMCR 1.39
- SFL 0.23
- MACD
- IMCR -0.15
- SFL 0.00
- Stochastic Oscillator
- IMCR 43.05
- SFL 89.61
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.
About SFL SFL Corporation Ltd
SFL Corp Ltd is an international ship-owning and chartering company. The company is engaged in transporting crude oil and oil products, dry bulk and containerized cargoes, freight of rolling cargo, and offshore drilling and related activities.